Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment February 16, 2022
Centivo survey reveals devastating toll of the healthcare affordability crisis on US workers February 8, 2022
EmpiRx Health Reaffirms Commitment to Employees, Partners with Valor Performance to Strengthen Leadership & Employee Experience February 4, 2022
Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care February 3, 2022
AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome February 3, 2022
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients February 3, 2022
Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform January 25, 2022
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy January 24, 2022